LookCloser.aipublic supplement evidence
Exact product checked · barcode not publishedBoysea · checked Aug 31, 2026 · on sale since Mar 28, 2024🇨🇳 USPTO wordmark owner · FUZHOU YINGSHI TRADING CO., LTD. · China
Quick read · Boysea

Boysea.Shilajit and Sea Moss Bundle - Sea Moss

Checked against public sources on August 31, 2026 · LookCloser does not sell or recommend supplements.

Does the marketing hold up?

🇨🇳 Brand owner: FUZHOU YINGSHI TRADING CO., LTD. · other, China. This tells you who is behind the brand and where the trademark record points. It does not by itself identify the manufacturer.

Is the dose real?Can’t check — no panel filed
What a serving costsNo price found for this exact barcode
Is it tested?No testing claim made
Who’s behind it?🇨🇳FUZHOU YINGSHI TRADING CO., LTD.other · China
Is it the real thing?No barcode publishedso it can’t be matched against certification, recall or other retailer records
Trouble on record?✓No recalls found
Quick read · 1 useful finding

What is worth knowing.

Headlines first. Open evidence only when you want the source trail.

CheckedCan you trust the review pattern?

Reviews rose from 227 to 304 between August 7, 2025 and August 30, 2026 — no sudden jump.

A count that moves steadily is ordinary. A sudden burst is what deserves a closer look.

Evidence and sources

Written reviews rose from 227 to 304 between August 7, 2025 and August 30, 2026. The largest rise inside any single 30-day window was about 25, so the count moved in steps rather than in one burst.

Keepa exact-listing historydated count history · exact listing
Locked evidence record →Open the full source-linked finding
What remains open 1
  • No FDA recall matched this brand in the current search.

These are evidence gaps, not strikes against the product.

Who owns the brand wordmark?
🇨🇳
FUZHOU YINGSHI TRADING CO., LTD.Other · exact supplement-class mark for BOYSEA
Registration8261841
Registered2026-05-19
AssignmentsNo transfers recorded

Filed address
FUZHOU FREE TRADE ZONE, 6238, AREA A, 15/F, COMPREHENSIVE BLDG, FUJIAN, 350000, CHINA

USPTO identifies the public owner or applicant behind this brand wordmark. This does not by itself identify the product manufacturer or prove where the product was made. Open USPTO source ↗

Research behind the findings

Dose and research context

We could not match an amount on this product to a studied range for the same ingredient, so these links are ingredient background rather than a measurement of this product.

NIH NCCIH — Ashwagandha ↗PubMed search: ashwagandha randomized trial ↗
Buying options

Where you can check or buy it

Only the submitted seller page is identity-certain. Other destinations are shown as leads until a shared UPC/GTIN confirms the exact product.

Amazon

Submitted listing
$29.99

Lowest New observed via Keepa on 2026-09-03.

View on Amazon ↗

iHerb

Not confirmed
No price confirmed

No matching product page was confirmed in the current record. Search results cannot be attached as this product until the UPC/GTIN matches.

Search iHerb ↗

Target

Not confirmed
No price confirmed

No matching product page was confirmed in the current record. Search results cannot be attached as this product until the UPC/GTIN matches.

Search Target ↗

Walmart

Not confirmed
No price confirmed

No matching product page was confirmed in the current record. Search results cannot be attached as this product until the UPC/GTIN matches.

Search Walmart ↗

Prices and stock are point-in-time observations. Related pages are never used as product evidence. No affiliate links; LookCloser earns nothing from these sellers.

Want to inspect the evidence?

The full report shows every source, the exact unresolved question, and the documentation that would settle it.

Read / share full evidence →

Record built September 03, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.